54768-47-7

Basic information

• Product Name: 3-CHLORO-4-NITRO (1H)INDAZOLE
• Synonyms: 3-CHLORO-4-NITRO (1H)INDAZOLE;1H-INDAZOLE,3-CHLORO-4-NITRO-
• CAS NO: 54768-47-7
• Molecular Formula: C₇H₄ClN₃O₂
• Molecular Weight: 197.58
• Mol File: 54768-47-7.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-CHLORO-4-NITRO (1H)INDAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CHLORO-4-NITRO (1H)INDAZOLE(54768-47-7)
• EPA Substance Registry System: 3-CHLORO-4-NITRO (1H)INDAZOLE(54768-47-7)

Safety Data

• Hazardous Substances Data: 54768-47-7(Hazardous Substances Data)

Usage

General Description

3-CHLORO-4-NITRO (1H)INDAZOLE is a chemical compound that belongs to the indazole family. It is characterized by a chloro group and a nitro group attached to the indazole ring structure. 3-CHLORO-4-NITRO (1H)INDAZOLE is commonly used in organic synthesis and pharmaceutical research. Its unique structure and reactivity make it a valuable building block for the synthesis of various organic compounds, including pharmaceuticals and agrochemicals. Additionally, the presence of the nitro group makes 3-CHLORO-4-NITRO (1H)INDAZOLE an important intermediate in the production of dyes and pigments. Overall, this chemical has versatile applications and serves as an important starting material for the synthesis of various valuable compounds.

Upstream product

• 2942-40-7 nitro-4 indazole 

Downstream Products

• 1415681-48-9 C₁₄H₁₂ClN₃O₃S 
• 1415681-49-0 C₁₆H₁₆ClN₃O₄S 
• 54768-48-8 C₇H₆ClN₃ 
• 1010102-31-4 tert-butyl 3-chloro-4-nitro-1H-indazole-1-carboxylate 
• 119888-28-7 7-(Benzenesulfonyl-dichloro-methyl)-3-chloro-4-nitro-1H-indazole 
• 119872-49-0 1-(7-Benzenesulfonylmethyl-3-chloro-4-nitro-indazol-1-yl)-ethanone 
• 119872-41-2 7-Benzenesulfonylmethyl-3-chloro-4-nitro-1H-indazole 

Relevant articles and documents

SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS

Compounds of Formula I: and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4, R5 and R6 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of fibrosis, bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases, pain and burns in a mammal

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.